Citigroup’s GoHealth GOCO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-438
| Closed | -$661 | – | 5943 |
|
|
2026
Q1 | $661 | Buy |
438
+225
| +106% | +$430 | ﹤0.01% | 5516 |
|
|
2025
Q4 | $458 | Buy |
213
+151
| +244% | +$516 | ﹤0.01% | 5596 |
|
|
2025
Q3 | $299 | Sell |
62
-1,577
| -96% | -$8.61K | ﹤0.01% | 5743 |
|
|
2025
Q2 | $9.1K | Sell |
1,639
-1,570
| -49% | -$12.4K | ﹤0.01% | 5203 |
|
|
2025
Q1 | $39.4K | Sell |
3,209
-355
| -10% | -$5.42K | ﹤0.01% | 4944 |
|
|
2024
Q4 | $47.7K | Buy |
3,564
+275
| +8% | +$3.13K | ﹤0.01% | 5098 |
|
|
2024
Q3 | $30.9K | Buy |
3,289
+2,276
| +225% | +$23K | ﹤0.01% | 5110 |
|
|
2024
Q2 | $9.85K | Buy |
1,013
+232
| +30% | +$2.29K | ﹤0.01% | 5145 |
|
|
2024
Q1 | $8.21K | Buy |
781
+179
| +30% | +$2.21K | ﹤0.01% | 5245 |
|
|
2023
Q4 | $8.03K | Buy |
602
+600
| +30,000% | +$8.21K | ﹤0.01% | 5246 |
|
|
2023
Q3 | $29 | Sell |
2
-1,166
| -100% | -$20.1K | ﹤0.01% | 5568 |
|
|
2023
Q2 | $23K | Buy |
+1,168
| New | +$18.3K | ﹤0.01% | 4926 |
|
|
2022
Q2 | – | Sell |
-925
| Closed | -$16K | – | 6389 |
|
|
2022
Q1 | $16K | Sell |
925
-288
| -24% | -$8.96K | ﹤0.01% | 5273 |
|
|
2021
Q4 | $69K | Sell |
1,213
-415
| -25% | -$27.7K | ﹤0.01% | 4923 |
|
|
2021
Q3 | $123K | Buy |
1,628
+323
| +25% | +$34.2K | ﹤0.01% | 4340 |
|
|
2021
Q2 | $219K | Buy |
1,305
+173
| +15% | +$30.3K | ﹤0.01% | 4196 |
|
|
2021
Q1 | $198K | Buy |
1,132
+467
| +70% | +$94.2K | ﹤0.01% | 4016 |
|
|
2020
Q4 | $136K | Sell |
665
-81
| -11% | -$15K | ﹤0.01% | 5285 |
|
|
2020
Q3 | $146K | Buy |
+746
| New | +$180K | ﹤0.01% | 4838 |
|
Other funds holding GOCO
EF
NEWAS
GBT
IA
Citigroup's GOCO Position: Q2 2026 in Review
Citigroup sold out of GoHealth (GOCO) in Q2 2026, closing a stake of 438 shares — an estimated $661 sold.
Citigroup first reported a position in GOCO in Q3 2020 and held it in 19 quarters. The position peaked at $219K in Q2 2021. 5 funds tracked by Wall St. Rank hold GOCO as of Q2 2026.
- Citigroup reported no remaining GoHealth position as of Q2 2026 after selling out during the quarter.
- Citigroup sold 438 GoHealth shares in Q2 2026, an estimated $661.
- Citigroup first reported a position in GoHealth in Q3 2020 and held it in 19 quarters.
- Citigroup's GoHealth position peaked at $219K in Q2 2021.
- 5 funds tracked by Wall St. Rank held GoHealth as of Q2 2026.
Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.